Methadone maintenance treatment in prisons: The New South Wales Experience.

This paper uses the New South Wales experience with methadone maintenance treatment in prison to address the question: should methadone maintenance treatment be provided in Australian prisons for opioid-dependent prisoners? First, it outlines three rationales for providing drug dependence treatment in prisons: as a way of giving prisoners access to community-based forms of drug treatment in the prison setting; as a measure to reduce recidivism in opioid-dependent prisoners; and as a measure to prevent the transmission of HIV and other infectious diseases within prisons, and to the sexual partners of prisoners on their release. Secondly, it reviews the kind of research evidence that supports the effectiveness of community-based methadone maintenance treatment in Australia. Thirdly, the effectiveness of the New South Wales Prison Methadone Programme, one of the few prison-based methadone programmes in the world, is evaluated in the light of the available research evidence.

[1]  R. Mattick,et al.  An Australian survey of the procedures used for the treatment of opiate users. , 1992, Drug and alcohol review.

[2]  D. D. Jarlais,et al.  The first and second decades of AIDS among injecting drug users. , 1992 .

[3]  W. Hall,et al.  Methadone maintenance and the human immunodeficiency virus: current issues in treatment and research. , 1992, British journal of addiction.

[4]  J. Bell,et al.  Changes in criminal activity after entering methadone maintenance. , 1992, British journal of addiction.

[5]  T. Vaughn,et al.  Variations in methadone treatment practices. Results from a national study. , 1992, JAMA.

[6]  D. Jarlais.  Difficult-to-reuse needles for the prevention of HIV infection among injecting drug users , 1992 .

[7]  R. Douglas,et al.  HIV prevalence and risk behaviours for HIV transmission in South Australian prisons. , 1991, AIDS.

[8]  J. Strang,et al.  Drugs, HIV, and prisons. , 1991, BMJ.

[9]  N. Heather,et al.  The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users. , 1991, AIDS.

[10]  J. Bell,et al.  Methadone dosage and retention of patients maintenance treatment , 1991, The Medical journal of Australia.

[11]  O. Blix,et al.  The Impact of Methadone Maintenance Treatment on the Spread of HIV Among IV Heroin Addicts in Sweden , 1991 .

[12]  W. Hall,et al.  Drug use, injecting practices and sexual behaviour of opioid users in Sydney, Australia. , 1990, British journal of addiction.

[13]  J. Bell,et al.  Heroin users seeking methadone treatment , 1990, The Medical journal of Australia.

[14]  L. Poretsky,et al.  Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients. , 1990, Archives of internal medicine.

[15]  P. M. Burgess,et al.  Methadone: old problems for new programmes. , 1990, Drug and alcohol review.

[16]  P. Selwyn,et al.  Risk factors for human immunodeficiency virus infection in intravenous drug users. , 1989, The New England journal of medicine.

[17]  S. Friedman,et al.  Reducing the risk of AIDS through methadone maintenance treatment. , 1988, Journal of health and social behavior.

[18]  A. Gorta,et al.  Process evaluation of NSW Department of Corrective Services Pre-release Methadone Program : Study 2 : views of inmates participating in the pilot Pre-release Methadone Program , 1987 .

[19]  L. Grönbladh,et al.  The Swedish methadone maintenance program: a controlled study. , 1981, Drug and alcohol dependence.

[20]  R. Elashoff,et al.  Therapeutic communities vs methadone maintenance. A prospective controlled study of narcotic addiction treatment: design and one-year follow-up. , 1980, Archives of general psychiatry.

[21]  R. Newman,et al.  DOUBLE-BLIND COMPARISON OF METHADONE AND PLACEBO MAINTENANCE TREATMENTS OF NARCOTIC ADDICTS IN HONG KONG , 1979, The Lancet.

[22]  I. Reynolds,et al.  THE USE OF METHADONE AS A TREATMENT TOOL FOR OPIATE ADDICTS: A TWO‐YEAR FOLLOW‐UP STUDY , 1976, The Medical journal of Australia.

[23]  E. Caine,et al.  Methadone treatment of randomly selected criminal addicts. , 1969, The New England journal of medicine.

[24]  V. Dole,et al.  Heroin addiction--a metabolic disease. , 1967, Archives of internal medicine.

[25]  V. Dole,et al.  A MEDICAL TREATMENT FOR DIACETYLMORPHINE (HEROIN) ADDICTION. A CLINICAL TRIAL WITH METHADONE HYDROCHLORIDE. , 1965, JAMA.

[26]  M. M. Eisenberg.  Surgery of the Gall Bladder and Bile Ducts , 1965 .